QCG
PRVA icon

Quadrant Capital Group’s Privia Health PRVA Stock Holding History

Quadrant Capital Group’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$469K Buy
22,778
+460
+2% +$10.4K 0.01% 931
2025
Q4 		$529K Buy
22,318
+7,031
+46% +$171K 0.02% 886
2025
Q3 		$381K Sell
15,287
-371
-2% -$7.98K 0.01% 1022
2025
Q2 		$360K Sell
15,658
-669
-4% -$15.5K 0.01% 1049
2025
Q1 		$367K Buy
16,327
+11,472
+236% +$267K 0.01% 950
2024
Q4 		$94.9K Buy
4,855
+511
+12% +$10.1K 0.01% 1082
2024
Q3 		$79.1K Buy
4,344
+292
+7% +$5.57K 0.01% 1211
2024
Q2 		$70.4K Buy
4,052
+720
+22% +$12.8K 0.01% 1214
2024
Q1 		$65.3K Buy
3,332
+2,324
+231% +$49.1K 0.01% 1239
2023
Q4 		$23.2K Sell
1,008
-666
-40% -$14.9K ﹤0.01% 1748
2023
Q3 		$38.5K Buy
1,674
+1,157
+224% +$29.4K ﹤0.01% 1396
2023
Q2 		$13.5K Buy
+517
New +$13.7K ﹤0.01% 1897

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Quadrant Capital Group's PRVA Position: Q1 2026 in Review

Quadrant Capital Group increased its Privia Health (PRVA) stake by 2.1% in Q1 2026, buying an estimated $10.4K and bringing the position to 22,778 shares worth $469K. The position accounts for 0.01% of the portfolio, ranked #931.

Quadrant Capital Group first reported a position in PRVA in Q2 2023 and has held it in 12 quarters since. The position peaked at $529K in Q4 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Quadrant Capital Group held 22,778 shares of Privia Health worth $469K as of Q1 2026.
  • Quadrant Capital Group bought 460 Privia Health shares in Q1 2026, an estimated $10.4K.
  • Privia Health made up 0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #931 holding.
  • Quadrant Capital Group first reported a position in Privia Health in Q2 2023 and has held it in 12 quarters since.
  • Quadrant Capital Group's Privia Health position peaked at $529K in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.